#news #biotech Biogen buys Pfizer’s unwanted neuro med for $75M as sell-off starts

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Biogen buys Pfizer’s unwanted neuro med for $75M as sell-off starts .As Pfizer clears house of its unwanted neuro assets, Biogen has become a buyer for one, namely a phase 2-ready schizophrenia drug.

from FierceBiotech: Biotech http://ift.tt/2FAAXNE